The pharmaceutical and medical device industries stand at an inflection point. After decades of reliance on traditional ...

With links to Cochlear, the US-based med-tech company has global ambitions for its spinal cord stimulator technology.

O. Rose Broderick reports on the health policies and technologies that govern people with disabilities’ lives. Before coming to STAT, she worked at WNYC’s Radiolab and Scientific American, and her ...

While there is no cure for Parkinson’s disease, there’s now a better way to control its involuntary muscle movements. In February, the FDA approved Medtronic’s BrainSense adaptive deep brain ...

How Medtronic spinal cord stimulation therapy helped one woman reclaim her life. For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her ...

It’s been a busy time for Medtronic, with lots of news coming out about their business, new products, and how they’re helping people. From updates on their financial performance to exciting new ...

Medtronic (NYSE:MDT) will add two new directors and establish additional committees after Elliott Investment Management emerged as one of its largest shareholders. The move was first reported by the ...

Medtronic (NYSE:MDT) officials today said that the company’s planned separation of its Diabetes business is on the right track. The medtech giant announced in May that it planned to separate the ...

If all goes to plan, Medtronic will have a different, leaner look within about 16 months. Medtronic’s expected separation of Medtronic Diabetes into a publicly traded company named MiniMed marks a new ...

Deal Overview On May 21, 2025, Medtronic plc (NYSE: MDT; $87.44, Market Capitalization: $112.1 billion), a global leader in medical technology, announced its intent to spin off its Diabetes business ...